Bath salts

Clinics in Laboratory Medicine

Volumn 32, Issue 3, 2012, Pages 415-427

  Gerona, Roy R ^a,b   Wu, Alan H B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Bath salts; Designer drugs; MDPV; Mephedrone; Synthetic cathinones

Indexed keywords

AMPHETAMINE DERIVATIVE; BATH SALT; CATHINONE DERIVATIVE; DESIGNER DRUG; LORAZEPAM; UNCLASSIFIED DRUG;

BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE MEASUREMENT; CHEMICAL ANALYSIS; DIAPHORESIS; DRUG ABUSE; DRUG INTOXICATION; DRUG LEGISLATION; ELECTROCARDIOGRAPHY; HEADACHE; HEART PALPITATION; HUMAN; HYPONATREMIA; LABORATORY DIAGNOSIS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; STRUCTURE ANALYSIS; TACHYCARDIA; XENOBIOTIC METABOLISM;

ADULT; DESIGNER DRUGS; FEMALE; HALLUCINOGENS; HUMANS; STREET DRUGS; UNITED STATES;

EID: 84865605780     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2012.07.010     Document Type: Review

References (48)

1. Kelly J. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 2011, 3:439-453.
2. Rosenbaum C.D., Carreiro S.P., Babu K.M. Here today, gone, tomorrow. . . and back again?. A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (Bath salts), Kratom, Salvia divinorum, methoxetamine and piperazines. J Med Toxicol 2012, 8:15-32.
3. Carvalho M., Carmo H., Costa V.M., et al. Toxicity of amphetamines: an update. Arch Toxicol 2012, [Epub ahead of print].
4. Fass J.A., Fass A.D., Garcia A.S. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother 2012, 46:436-441.
5. Caroll F.I., Lewin A.H., Mascarella S.W., et al. Designer drugs: a medicinal chemistry perspective. Ann N Y Acad Sci 2012, 1248:18-38.
6. Hill S., Thomas S. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011, 49:705-719.
7. Bejhadj-Tahar H., Sadeg N. Methcathinone: a new postindustrial drug. Forensic Sci Int 2005, 197:159.
8. De Bie R.M., Gladstone R.M., Strafella A.P., et al. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. Arch Neurol 2007, 64(6):886-889.
9. Meyer M., Wilhelm J., Peters F.T., et al. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 2010, 397:1225-1233.
10. Meyer M., Du P., Schuster F., et al. Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high resolution MS and its detectability in urine by GC-MS. J Mass Spectrosc 2010, 45:1426-1442.
11. Strano-Rossi S., Cadwallader A., de la Torre X., et al. Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2010, 24:2706-2714.
12. Pawlik E., Plässer G., Mahler H., et al. Studies on the phase I metabolism of the new designer drug 3-fluoromethcathinone using rabbit liver slices. Int J Legal Med 2011, 126:231-240.
13. Kamata H.T., Shima N., Zaitsu K., et al. Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 2006, 36:709-723.
14. Mueller D., Rentsch K. Generation of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinones. Anal Bioanal Chem 2012, 402:2141-2151.
15. Feyissa A., Kelly J. A review of the pharmacological properties of khat. Prog Neuro-Psychopharmacol Biol Psych 2008, 32:147-166.
16. Springer D., Peters F.T., Fritschi G., et al. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2001, 773:25-33.
17. Springer D., Peters F.T., Fritschi G., et al. New designer drug 4'-methyl-α-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 789:79-91.
18. Springer D., Fritschi G., Maurer H.H. Metabolism and toxicological detection of the new designer drug 4'-methoxy-α-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 793:331-342.
19. Springer D., Peters F.T., Fritschi G., et al. Metabolism and toxicological detection of the new designer drug 3',4'-methylenedioxy-α-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 793:377-388.
20. Springer D., Fritschi G., Maurer H.H. Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of 4'-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 796:253-266.
21. Sauer C., Peters F.T., Haas C., et al. New designer drug α-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. J Mass Spectrom 2008, 44:952-964.
22. Meyer M.R., Vollmar C., Schwaninger A.E., et al. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and their detectability in urine. J Mass Spectrom 2011, 47:253-262.
23. Prosser J., Nelson L. The toxicology of bath salts: a review of synthetic cathinones. J Med Tox 2011, [Epub ahead of print].
24. Zaitsu K., Katagi M., Tatsuno M., et al. Recently abused beta-keto derivatives of methylenedioxyphenylalkylamines: a review of their metabolisms and toxicological analysis. Forensic Toxicol 2011, 29:73-84.
25. Carhart-Harris R.L., King L.A., Nutt D.J. A web-based survey on mephedrone. Drug Alcohol Depend 2011, s118:19-22.
26. James D., Adams R.D., Spears R., et al. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg Med J 2010, 28:686-689.
27. Michaelis W., Russell J.H., Schindler O. The metabolism of pyrovalerone hydrochloride. J Med Chem 1970, 13:497-503.
28. Torrannce H., Cooper G. The detection of mepherdrone (4-methylmethcathinone) in four fatalities in Scotland. Forensic Sci Int 2010, 202:e62-e63.
29. Frison G., Gregio M., Zamengo L., et al. Gas chromatography/mass spectrometry determination of mephedrone in drug seizures after derivatization with 2,2,2-trichloroethyl chloroformate. Rapid Commun Mass Spectrom 2011, 25:387-390.
30. Maheux C., Copeland C. Characterization of three methcathinone analogs: 4-methylmethcathinone, methylone and bk-MBDB. DEA Microgram J 2010, 7:42-49.
31. Jankovics P., Varadi A., Tolgyesi L., et al. Identification and characterization of the new designer drug 4'-methylcathinone (4-MEC) and elaboration of a novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) screening method for seven different methcathinone analogs. Forensic Sci Int 2011, 210:213-220.
32. Bell C., George C., Kicman A.T., et al. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test Anal 2011, 3:496-504.
33. Kikura-Hanajiri R., Kawamura M., Saisho K., et al. The disposition into hair of new designer drugs: methylone, MBDB, methcathinone. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 855:121-126.
34. Sørenson LK. Determination of cathinones and related ephedrines in forensic whole blood samples by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879:727-36.
35. Gibbons S., Zloh M. An analysis of the legal high mephedrone. Bioorg Med Chem Lett 2010, 20:4135-4139.
36. Power J.D., McGlynn P., Clarke K., et al. The analysis of substituted cathinones. Part 1: chemical analysis of 2-, 3-, and 4-methylmethcathinone. Forensic Sci Int 2011, 212:6-12.
37. McDermott S.D., Power J.D., Kavanagh P., et al. The analysis of substituted cathinones. Part 2: an investigation into the phenylacetone based isomers of 4-methymethcathinone and N-ethylcathinone. Forensic Sci Int 2011, 22:120-127.
38. Wood D., Dargan P. Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity. Prog Neuropsychopharmacol Biol Psychiatry 2008, [Epub ahead of print].
39. Brandt S.D., Sumnall H.R., Measham F., et al. Analyses of second-generation "legal highs" in the UK: initial findings. Drug Test Anal 2010, 2:377-382.
40. Brandt S.D., Freeman S., Sumnall H.R., et al. Analysis of NRG "legal highs" in the UK: Identification and formation of novel cathinones. Drug Test Anal 2011, 3:569-575.
41. De Paoli G., Maskell P., Pounder D. Naphyrone: analytical profile of the new "legal high" substitute for mephedrone. J Forensic Legal Med 2012, 18:93.
42. Baron M., Elie M., Elie L. An analysis of legal highs- do they contain what it says on the tin. Drug Test Anal 2011, 3:576-581.
43. Spiller H.A., Ryan M.L., Weston R.G., et al. Clinical experience with analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011, 49:499-505.
44. Schedules of controlled substance: temporary placement of synthetic cathinones into Schedule I. Federal Regist 2011, 76(204):65371-65375. Drug Enforcement Administration.
45. Shanks K.G., Dahn T., Behonick G., et al. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-preformance liquid chromatography and time-of-flight mass spectrometry. J Anal Toxicol 2012, 36:360-371.
46. Kriikku P., Wilhelm L., Schwarz O., et al. New designer drug of abuse: 3,4-methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Sci Int 2011, 210:195-200.
47. Ojanperä I.A., Heikman P.K., Rasanen I.J. Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry. Ther Drug Monit 2011, 33(2):257-263. 2011.
48. Thornton S.L., Gerona R.R., Thomaszwski C.A. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine and product quantification. J Med Toxicol 2012, [Epub ahead of print].